Showing results (1571-1580 of 1,836) with videos related to

Sort By:
Pageof 184
Signal Transduction and Targeted Therapy|December 22, 2017
UV-induced damage to DNA: effect of cytosine methylation on pyrimidine dimerizationLara Martinez-Fernandez, Akos Banyasz, Luciana Esposito, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
Redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategyJingwen Jiang, Kui Wang, Yan Chen, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
Targeting cellular pathways in glioblastoma multiformeJoshua R D Pearson, Tarik Regad
Signal Transduction and Targeted Therapy|December 22, 2017
Sympathetic transmitters control thermogenic efficacy of brown adipocytes by modulating mitochondrial complex VTao-Rong Xie, Chun-Feng Liu, Jian-Sheng Kang
Signal Transduction and Targeted Therapy|March 13, 2018
DNA methylation profile is associated with the osteogenic potential of three distinct human odontogenic stem cellsTingting Ai, Jieni Zhang, Xuedong Wang, et al.
Signal Transduction and Targeted Therapy|March 20, 2026
SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trialHerui Yao, Min Yan, Zhongsheng Tong, et al.
Signal Transduction and Targeted Therapy|March 24, 2026
Visinin-like protein 1 disrupts calcium homeostasis and promotes atrial fibrillation in human and rodent modelsKe Xiong, Guanghua Wang, Desheng Li, et al.
Signal Transduction and Targeted Therapy|March 24, 2026
Potent and selective LSD1 inhibitor DC551040 reveals a promising combination therapy for AML with insight into epigenetic dysregulationJiang Wang, Hanlin Wang, Runhua Du, et al.
Signal Transduction and Targeted Therapy|April 12, 2026
Bioengineered iPSC-derived human macrophages with increased angiotensin-converting enzyme (ACE) expression suppress solid tumor growthTomohiro Shibata, Shabir Bhat, DuoYao Cao, et al.
Signal Transduction and Targeted Therapy|April 9, 2026
Irinotecan with trifluridine/tipiracil and bevacizumab for second-line metastatic colorectal cancer: a phase II multicenter studyWenwei Yang, Jing Zhang, Ping Liang, et al.
Pageof 184